Explore

Trendline Trendline
Pfizer and Innovent Biologics Forge $10.5 Billion Oncology Partnership, Boosting Innovent Shares

Pfizer and Innovent Biologics Forge $10.5 Billion Oncology Partnership, Boosting Innovent Shares

Pfizer and Innovent Biologics Forge $10.5 Billion Oncology Partnership, Boosting Innovent Shares
Trendline Trendline
Vyome Holdings Reports Strong Q1 2026 Financials and Key FDA Filings

Vyome Holdings Reports Strong Q1 2026 Financials and Key FDA Filings

Vyome Holdings Reports Strong Q1 2026 Financials and Key FDA Filings
Trendline Trendline
Innovent Biologics Shares Surge After $10.5 Billion Deal with Pfizer

Innovent Biologics Shares Surge After $10.5 Billion Deal with Pfizer

Innovent Biologics Shares Surge After $10.5 Billion Deal with Pfizer
Trendline Trendline
Exelixis to Present at Major Healthcare Conferences, Highlighting Oncology Innovations

Exelixis to Present at Major Healthcare Conferences, Highlighting Oncology Innovations

Exelixis to Present at Major Healthcare Conferences, Highlighting Oncology Innovations
Trendline Trendline
GeneDx to Present at Goldman Sachs Global Healthcare Conference

GeneDx to Present at Goldman Sachs Global Healthcare Conference

GeneDx to Present at Goldman Sachs Global Healthcare Conference
Trendline Trendline
Pulse Biosciences to Present at Goldman Sachs Healthcare Conference, Highlighting nPulse Technology

Pulse Biosciences to Present at Goldman Sachs Healthcare Conference, Highlighting nPulse Technology

Pulse Biosciences to Present at Goldman Sachs Healthcare Conference, Highlighting nPulse Technology
Trendline Trendline
Kura Oncology's New Cancer Drug Shows Promise, Potential $2 Billion Market Opportunity

Kura Oncology's New Cancer Drug Shows Promise, Potential $2 Billion Market Opportunity

Kura Oncology's New Cancer Drug Shows Promise, Potential $2 Billion Market Opportunity
Trendline Trendline
Shoulder Innovations to Present at Goldman Sachs Global Healthcare Conference

Shoulder Innovations to Present at Goldman Sachs Global Healthcare Conference

Shoulder Innovations to Present at Goldman Sachs Global Healthcare Conference
Trendline Trendline
Kardigan Files for IPO to Fund Cardiovascular Drug Development

Kardigan Files for IPO to Fund Cardiovascular Drug Development

Kardigan Files for IPO to Fund Cardiovascular Drug Development
Trendline Trendline
Shoulder Innovations to Participate in Goldman Sachs Healthcare Conference, Aiming to Transform Surgical Care

Shoulder Innovations to Participate in Goldman Sachs Healthcare Conference, Aiming to Transform Surgical Care

Shoulder Innovations to Participate in Goldman Sachs Healthcare Conference, Aiming to Transform Surgical Care
Trendline Trendline
Eli Lilly Expands Vaccine Portfolio Amid Moderna's Stock Surge

Eli Lilly Expands Vaccine Portfolio Amid Moderna's Stock Surge

Eli Lilly Expands Vaccine Portfolio Amid Moderna's Stock Surge
Trendline Trendline
Eli Lilly Expands Vaccine Portfolio Amid Moderna's Stock Surge Due to Hantavirus Concerns

Eli Lilly Expands Vaccine Portfolio Amid Moderna's Stock Surge Due to Hantavirus Concerns

Eli Lilly Expands Vaccine Portfolio Amid Moderna's Stock Surge Due to Hantavirus Concerns